Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Inozyme financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$4.6
2024-10-29
Market Capitalization
$310 M
2024-10-29
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|
| General and administrative expense | 10.5M | 18.9M | 20.8M | 20.8M | 20.8M |
| Operating expense total | 57.0M | 56.6M | 68.7M | 104.0M | |
| EBIT | (57.0M) | (56.6M) | (68.7M) | (75.6M) | (104.0M) |
| Interest income | 370.0K | 211.0K | 1.9M | 7.8M | 7.7M |
| Interest expense | 170.0K | 3.3M | 4.4M | ||
| Net Income | (56.4M) | (56.6M) | (67.1M) | (71.2M) | (102.0M) |
| EPS | (1.8) | (1.0) | (1.6) |